FI974640A0 - Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit - Google Patents

Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit

Info

Publication number
FI974640A0
FI974640A0 FI974640A FI974640A FI974640A0 FI 974640 A0 FI974640 A0 FI 974640A0 FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A0 FI974640 A0 FI 974640A0
Authority
FI
Finland
Prior art keywords
isochromanes
migraine
disubstituted
treatment
disubstituted isochromanes
Prior art date
Application number
FI974640A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974640A (fi
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI974640A publication Critical patent/FI974640A/fi
Publication of FI974640A0 publication Critical patent/FI974640A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI974640A 1995-06-30 1997-12-30 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit FI974640A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (fr) 1995-06-30 1996-06-07 Isochromans 1,6-disubstitues destines au traitement des cephalees de type migraine

Publications (2)

Publication Number Publication Date
FI974640A FI974640A (fi) 1997-12-30
FI974640A0 true FI974640A0 (fi) 1997-12-30

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974640A FI974640A0 (fi) 1995-06-30 1997-12-30 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit

Country Status (12)

Country Link
EP (1) EP0836599A1 (fr)
JP (1) JPH11509532A (fr)
AU (1) AU6252296A (fr)
BR (1) BR9609631A (fr)
CA (1) CA2225282A1 (fr)
CZ (1) CZ418597A3 (fr)
FI (1) FI974640A0 (fr)
MX (1) MX9710260A (fr)
NO (1) NO976112L (fr)
PL (1) PL324319A1 (fr)
SK (1) SK164297A3 (fr)
WO (1) WO1997002259A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (pt) 2004-05-05 2007-11-20 Hoffmann La Roche arilsulfonil benzodioxanos úteis para modulação do receptor de 5-ht6, do receptor de 5ht2a ou ambos
WO2006066756A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de chromane utiles dans le traitement des troubles du systeme nerveux central
SI1831159T1 (sl) 2004-12-21 2010-04-30 Hoffmann La Roche Derivati tetralina in indana ter njune uporabe
WO2006066748A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de tetraline et d'indane et utilisations de ceux-ci en tant qu'antagonistes de la 5-ht
DE602005017663D1 (de) 2004-12-21 2009-12-24 Hoffmann La Roche Tetralin- und indanderivate und anwendungen davon
CA2592001A1 (fr) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Derives de chromane et utilisation de ces derniers comme ligands du recepteur 5-ht
BRPI0618206A2 (pt) 2005-11-03 2011-08-23 Hoffmann La Roche arilsulfonil cromanos como inibidores de 5-ht6, bem como composição farmacêutica, uso e processo para produção dos mesmos
MX2008015843A (es) 2006-06-20 2009-01-09 Hoffmann La Roche Derivados de tetralina e indano y usos de los mismos.
CA2655524A1 (fr) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Derives d'arylsulfonamidyl tetraline et leurs utilisations
EP2041079A1 (fr) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Derives arylsulfonylnaphtalene et leurs utilisations
EP2404897A4 (fr) * 2009-03-05 2014-02-26 Sumitomo Chemical Co Procédé de production de benzène diméthanol à substitution halogène

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
ES2133714T3 (es) * 1993-12-28 1999-09-16 Upjohn Co Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares.

Also Published As

Publication number Publication date
NO976112D0 (no) 1997-12-29
JPH11509532A (ja) 1999-08-24
PL324319A1 (en) 1998-05-25
SK164297A3 (en) 1998-09-09
CA2225282A1 (fr) 1997-01-23
MX9710260A (es) 1998-03-29
NO976112L (no) 1998-03-02
BR9609631A (pt) 1999-03-02
CZ418597A3 (cs) 1998-06-17
FI974640A (fi) 1997-12-30
WO1997002259A1 (fr) 1997-01-23
AU6252296A (en) 1997-02-05
EP0836599A1 (fr) 1998-04-22

Similar Documents

Publication Publication Date Title
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
IT1292552B1 (it) Dispositivo per l'applicazione di rivestimenti.
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
IL113057A0 (en) Compositions for the treatment of dandruff
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
ES1031096Y (es) Ducha antivandalica.
FI970039A (fi) Menetelmä 5-aryyli-2,4-dialkyyli-3H-1,2,3-triatsoli-3-tionien valmistamiseksi
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
RU95117268A (ru) Средство для лечения атопического дерматита
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
FI953860A0 (fi) Yhdistelmäpalkki
ITRM940468A0 (it) "impiego di esteruretani per ls riconcia".
ITTV940061A0 (it) "pedana, particolarmente per la pratica della scherma".
FI954263A0 (fi) Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar